CGBIO Co., Ltd. is a South Korean company specializing in regenerative medicine and biomaterials. It develops and manufactures products for spine care, wound healing, and aesthetics, including lifting threads. The firm operates as an affiliate of Daewoong Pharmaceutical. In 2026, negotiations for a controlling stake acquisition by IMM Private Equity were terminated after failing to reach agreement on terms.
Official website: cgbio.co.kr
To provide comprehensive coverage, we aggregate data and news under the name CGBIO, encompassing the following company names, divisions, and related entities:
CG Bio Co., Ltd..
This list encompasses current and former names, alternate names, and key divisions associated with CGBIO, ensuring you can easily find all relevant information under a single, unified profile.
